Integrated Diagnostics Holdings plc (IDGXF)
USD 0.32
(0.0%)
USD 0.32
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.66 Billion EGP | -6.31% |
| 2022 | 2.84 Billion EGP | -17.22% |
| 2021 | 3.44 Billion EGP | 96.55% |
| 2020 | 1.75 Billion EGP | 25.51% |
| 2019 | 1.39 Billion EGP | 35.04% |
| 2018 | 1.03 Billion EGP | 29.51% |
| 2017 | 797.72 Million EGP | 6.9% |
| 2016 | 746.21 Million EGP | 37.98% |
| 2015 | 540.82 Million EGP | 42.48% |
| 2014 | 379.58 Million EGP | 12.34% |
| 2013 | 337.89 Million EGP | -9.6% |
| 2012 | 373.76 Million EGP | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 3.21 Billion EGP | 4.62% |
| 2024 Q1 | 3.07 Billion EGP | 15.18% |
| 2023 Q4 | 2.66 Billion EGP | -1.52% |
| 2023 Q1 | 2.72 Billion EGP | -4.28% |
| 2023 FY | 2.66 Billion EGP | -6.31% |
| 2023 Q2 | 2.61 Billion EGP | -4.01% |
| 2023 Q3 | 2.71 Billion EGP | 3.54% |
| 2022 Q2 | 4.35 Billion EGP | 17.59% |
| 2022 Q4 | 2.84 Billion EGP | 1.21% |
| 2022 Q3 | 2.81 Billion EGP | -35.35% |
| 2022 FY | 2.84 Billion EGP | -17.22% |
| 2022 Q1 | 3.7 Billion EGP | 7.6% |
| 2021 Q4 | 3.44 Billion EGP | 15.1% |
| 2021 Q3 | 2.99 Billion EGP | 5.66% |
| 2021 FY | 3.44 Billion EGP | 96.55% |
| 2021 Q2 | 2.83 Billion EGP | 0.0% |
| 2020 Q1 | - EGP | -100.0% |
| 2020 Q4 | 1.75 Billion EGP | 0.0% |
| 2020 Q2 | 1.28 Billion EGP | 0.0% |
| 2020 FY | 1.75 Billion EGP | 25.51% |
| 2019 Q2 | 1.24 Billion EGP | 0.0% |
| 2019 FY | 1.39 Billion EGP | 35.04% |
| 2019 Q4 | 1.39 Billion EGP | 0.0% |
| 2019 Q1 | - EGP | -100.0% |
| 2018 Q3 | - EGP | -100.0% |
| 2018 Q4 | 1.03 Billion EGP | 0.0% |
| 2018 FY | 1.03 Billion EGP | 29.51% |
| 2018 Q1 | 733.58 Million EGP | -8.04% |
| 2018 Q2 | 733.58 Million EGP | 0.0% |
| 2017 Q4 | 797.72 Million EGP | 0.0% |
| 2017 Q1 | 750.36 Million EGP | 0.56% |
| 2017 Q2 | 750.36 Million EGP | 0.0% |
| 2017 FY | 797.72 Million EGP | 6.9% |
| 2016 Q1 | 516.8 Million EGP | -4.44% |
| 2016 FY | 746.21 Million EGP | 37.98% |
| 2016 Q2 | 516.81 Million EGP | 0.0% |
| 2016 Q4 | 746.21 Million EGP | 0.0% |
| 2016 Q3 | - EGP | -100.0% |
| 2015 Q1 | 435.41 Million EGP | 14.71% |
| 2015 FY | 540.82 Million EGP | 42.48% |
| 2015 Q4 | 540.82 Million EGP | 0.0% |
| 2015 Q2 | 435.41 Million EGP | 0.0% |
| 2014 Q4 | 379.58 Million EGP | 0.0% |
| 2014 Q1 | - EGP | -100.0% |
| 2014 FY | 379.58 Million EGP | 12.34% |
| 2013 Q4 | 337.89 Million EGP | 0.0% |
| 2013 FY | 337.89 Million EGP | -9.6% |
| 2012 FY | 373.76 Million EGP | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Bio Medica Corporation | 3.6 Million USD | -73889.412% |
| Arrayit Corporation | 7.49 Million USD | -35510.016% |
| Atlantic International Corp. | 3.82 Million USD | -69625.891% |
| Biocept, Inc. | 22.01 Million USD | -12027.098% |
| Bioqual, Inc. | 18.93 Million USD | -13996.206% |
| CardioGenics Holdings Inc | 1.79 Million USD | -148627.16% |
| DermTech, Inc. | 64.75 Million USD | -4022.52% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | -263.216% |
| HTG Molecular Diagnostics, Inc. | 12.38 Million USD | -21452.939% |
| iMD Companies, Inc. | 1.67 Million USD | -159350.035% |
| IDenta Corp. | 1.01 Million USD | -263386.84% |
| Interpace Biosciences, Inc. | 28.15 Million USD | -9380.904% |
| Integrative Health Technologies, Inc. | 297.94 Thousand USD | -895877.473% |
| InVitro International | 78.99 Thousand USD | -3379489.821% |
| Lumos Diagnostics Holdings Limited | 19.72 Million USD | -13431.036% |
| Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -2064555.792% |
| Medical Imaging Corp. | 9.51 Million USD | -27949.951% |
| NovelStem International Corp. | 4.2 Million USD | -63368.565% |
| Optigenex Inc. | 9.57 Million USD | -27793.055% |
| PharmChem, Inc. | 558.64 Thousand USD | -477757.753% |
| Proteome Sciences plc | 18.48 Million USD | -14338.48% |
| Response Genetics, Inc | 15.86 Million USD | -16724.466% |
| Rennova Health, Inc. | 49.66 Million USD | -5274.835% |
| RushNet, Inc. | 6.23 Million USD | -42687.97% |
| ScreenPro Security Inc. | 1.6 Million USD | -166684.936% |
| Stella Diagnostics Inc. | 18 Million USD | -14726.315% |
| StageZero Life Sciences Ltd. | 8.2 Million USD | -32439.512% |
| Todos Medical Ltd. | 50.15 Million USD | -5222.364% |